A malignant tumor of striated muscle origin, rhabdomyosarcoma (RMS) is a childhood tumor
that has benefited from nearly 30 years of multimodality therapy, culminating in a> 70 …

Rhabdomyosarcoma (RMS) is a malignant childhood tumor of mesenchymal origin that
currently has a greater than 70% overall 5-year survival. Multimodality treatment is …

Importance of the field: Cytarabine is a polar nucleoside drug used for the treatment of
myeloid leukemia and non-Hodgkin's lymphoma. The drug has a short plasma half-life, low …

Objective Recent many studies have shown that whole body “diffusion-weighted imaging
with background body signal suppression”(DWIBS) seems a beneficial tool having higher …

BACKGROUND Lymph node metastases are an important cause of treatment failure for
pediatric and adolescent/young adult (AYA) sarcoma patients. Nodal sampling is …

Rhabdomyosarcoma (RMS) is a malignant tumor that represents the most common form of
pediatric soft tissue sarcoma. It arises from mesenchymal origin and forms part of the group …

The Nuclear Medicine Global Initiative (NMGI) was formed in 2012 and consists of 13
international organizations with direct involvement in nuclear medicine. The underlying …

Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children,
but also occurs in adolescents and (young) adults (AYA). Despite dramatic survival …

Imaging modalities play an important complimentary role to traditional history, physical
examination, and laboratory tests in the diagnosis and management of patient disease …

Pediatric whole-body (WB) magnetic resonance imaging (MRI) is an established technique
that, with improved accessibility and advances in technology, is being used with increasing …